LakeShore Biopharma Co., Ltd
LSB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$100 | -$433 | -$145 | -$106 |
| Dep. & Amort. | $37 | $42 | $37 | $31 |
| Deferred Tax | -$4 | -$22 | $1 | $5 |
| Stock-Based Comp. | $14 | $10 | $4 | $8 |
| Change in WC | -$115 | -$46 | -$93 | -$139 |
| Other Non-Cash | $48 | $154 | $14 | $27 |
| Operating Cash Flow | -$121 | -$295 | -$182 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$44 | -$57 | -$299 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$4 | $0 | $0 | $0 |
| Investing Cash Flow | -$17 | -$44 | -$57 | -$299 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$79 | $101 | $365 |
| Stock Issued | $0 | $284 | $0 | $202 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $217 | $0 |
| Financing Cash Flow | -$4 | $205 | $317 | $365 |
| Forex Effect | $3 | $10 | $21 | -$11 |
| Net Chg. in Cash | -$139 | -$124 | $99 | -$119 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $247 | $370 | $271 | $390 |
| End Cash | $107 | $247 | $370 | $1 |
| Free Cash Flow | -$139 | -$339 | -$240 | -$300 |